| Drug Name |
Gadodiamide hydrate |
| Drug ID |
BADD_D00986 |
| Description |
Gadodiamide is a paramagnetic gadolinium-based contrast agent (GBCA) that is used in MR imaging procedures to assist in the visualization of blood vessels. It is intravenously injected and is commonly marketed under the trade name Omniscan. |
| Indications and Usage |
For intravenous use in MRI to visualize lesions with abnormal vascularity (or those thought to cause abnormalities in the blood-brain barrier) in the brain (intracranial lesions), spine, and associated tissues. |
| Marketing Status |
approved; investigational |
| ATC Code |
V08CA03 |
| DrugBank ID |
DB00225
|
| KEGG ID |
D01645
|
| MeSH ID |
C064925
|
| PubChem ID |
153921
|
| TTD Drug ID |
D03EEH
|
| NDC Product Code |
0407-0691; 0407-0690; 71806-069 |
| UNII |
0RPE15QPL0
|
| Synonyms |
gadodiamide | Gd-DTPA bis-(methylamide) | Gd-DTPA-BMA | Omniscan | Omniscan Unique Softpack |
